Market Watch Highlights: Amneal Pharmaceuticals Inc (AMRX) Ends on an Downturn Note at 8.55

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Amneal Pharmaceuticals Inc’s stock clocked out at $8.55, down -0.47% from its previous closing price of $8.59. In other words, the price has decreased by -$0.47 from its previous closing price. On the day, 0.78 million shares were traded. AMRX stock price reached its highest trading level at $8.585 during the session, while it also had its lowest trading level at $8.415.

Ratios:

To gain a deeper understanding of AMRX’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 53.34 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 58.80. For the most recent quarter (mrq), Quick Ratio is recorded 0.82 and its Current Ratio is at 1.33.

Goldman Upgraded its Sell to Buy on March 08, 2021, whereas the target price for the stock was revised from $4 to $6.50.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 15 ’24 when BOYER ANDREW S sold 40,225 shares for $7.85 per share. The transaction valued at 315,766 led to the insider holds 256,670 shares of the business.

BOYER ANDREW S sold 22,486 shares of AMRX for $175,616 on Aug 14 ’24. The Executive Vice President now owns 296,895 shares after completing the transaction at $7.81 per share. On Aug 14 ’24, another insider, Shah Nikita, who serves as the Executive Vice President of the company, sold 100,000 shares for $7.75 each. As a result, the insider received 775,000 and left with 291,666 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMRX now has a Market Capitalization of 2646592768 and an Enterprise Value of 5377911296. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.02. Its current Enterprise Value per Revenue stands at 2.07 whereas that against EBITDA is 9.33.

Stock Price History:

Over the past 52 weeks, AMRX has reached a high of $8.94, while it has fallen to a 52-week low of $3.36. The 50-Day Moving Average of the stock is 5.72%, while the 200-Day Moving Average is calculated to be 29.70%.

Shares Statistics:

It appears that AMRX traded 1.32M shares on average per day over the past three months and 1417260 shares per day over the past ten days. A total of 306.56M shares are outstanding, with a floating share count of 119.85M. Insiders hold about 61.28% of the company’s shares, while institutions hold 39.45% stake in the company. Shares short for AMRX as of 1726185600 were 4639253 with a Short Ratio of 3.52, compared to 1723680000 on 4259337. Therefore, it implies a Short% of Shares Outstanding of 4639253 and a Short% of Float of 1.7999999999999998.

Most Popular